Agathobacter rectalis: NCBI 39491, [species]

Back to details

| "Bacteroides rectalis" Hauduroy et al. 1937| "Pseudobacterium rectale" (Hauduroy et al. 1937) Krasil'nikov 1949| 'Roseburia rectale'| [Eubacterium] rectale| Agathobacter rectalis| Agathobacter rectalis (Hauduroy et al. 1937) Rosero et al. 2016| ATCC 33656| Bacteroides rectalis| CIP 105953| DSM 17629| Eubacterium rectale| Eubacterium rectale (Hauduroy et al. 1937) Prevot 1938| NCIMB 14373| not ATCC 25578| not VPI 0989| Pseudobacterium rectale| Roseburia rectale| strain A1-86| VPI 0990

  1. Maintaining gut barrier function: SCFAs produced by gut bacteria help maintain the integrity of the intestinal epithelium and strengthen the gut barrier, which helps prevent the translocation of harmful substances and pathogens from the gut lumen into the bloodstream.

  2. Regulating immune function: SCFAs have immunomodulatory effects and can help regulate immune responses in the gut. They promote the development and function of regulatory T cells (Tregs), which play a role in immune tolerance and inflammation control.

  3. Providing a energy source: Butyrate, in particular, is an important energy source for colonocytes (cells lining the colon). It helps maintain the health and function of the colonic mucosa and may protect against colorectal cancer and other gastrointestinal disorders.

  4. Modulating metabolic health: SCFAs have been linked to improvements in metabolic health, including glucose and lipid metabolism. They may help regulate appetite, insulin sensitivity, and energy balance, potentially reducing the risk of obesity and metabolic syndrome.

Other Sources for more information:

You do not have any samples under this email

📹Video Walkthru of this Page

Agathobacter rectalis impacts on other bacteria of the same rank

Other bacteria of the same rank impacting Agathobacter rectalis

This is an Academic site. It generates theoretical models of what may benefit a specific microbiome results.

Explanations /Info /Descriptions are influenced by Large Language Models and may not be accurate and include some hallucinations.Please report any to us for correction.

Copyright 2016 - 2025 Lassesen Consulting, LLC[2007], DBA, Microbiome Prescription All rights served.
Permission to data scrap or reverse engineer is explicitly denied to all users.U.S.Code Title 18 PART I CHAPTER 47 § 1030, CETS No.185, CFAA
Use of data on this site is prohibited except under written license.There is no charge for individual personal use.Use for any commercial applications or research requires a written license.
Caveat emptor: Analysis and suggestions are based on modelling(and thus infererence ) based on studies.The data sources are usually given for those that wish to consider alternative inferences.theories and models.
Inventions /Methodologies on this site are Patent Pending.

Microbiome Prescription do not make any representations that data or analyses available on this site is suitable for human diagnostic purposes, for informing treatment decisions, or for any other purposes and accept no responsibility or liability whatsoever for such use.
This site is not in strict compliance with Personal Health Information Laws. [216.73.216 ]

Due to AI drones slamming this site, we have added IP blocking on excessive calls. Email us if you get blocked and send this [216.73.216 ]